Swiss chemicals group Lonza has said that a new small-scale
production plant at its Visp site will come on stream in July and
will boost its services in the area of exclusive manufacturing of
GEA Filtration has introduced a microfiltration plant for the
PharmaChem industries that, it claims, can perform studies on the
full range of filtration technologies using all types of filter
Cambrex has initiated a project aimed at constructing a new
facility to accommodate four cGMP-compliant suites dedicated to
cell therapy manufacturing. The company said the expansion would
increase its manufacturing capacity by 100...
Just over a year after acquiring the FSG business from Vivendi for
$360 million (€307m), Pall Corp has reported a healthy hike in
fiscal third-quarter sales and profits and once again raised its
earnings forecast for 2003.
Akzo Nobel's Diosynth unit has signed a multi-year contract to
manufacture and supply the active pharmaceutical ingredient for
Pfizer's growth hormone receptor antagonist Somavert. The value of
the agreement was not disclosed,...
AstraZeneca has opened a new multi-million dollar research facility
in Bangalore, India, which will focus principally on finding new
treatments for tuberculosis, a disease which is diagnosed in about
8 million people worldwide each...
Dutch firm Crucell has expanded its licensing agreement with US
drug major Merck & Co relating to PER.C6, the former's
proprietary cell technology platform used for the production of
The European Union's Employment, Social Policy, Health and Consumer
Affairs Council agreed on 2 June not to press ahead with proposals
to implement a mandatory centralised marketing authorisation scheme
for all medicines.